Nautilus Biotechnolgy/$NAUT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nautilus Biotechnolgy
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
- Ticker
- $NAUT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 127
- Headquarters
- Seattle, United States
- Website
- www.nautilus.bio
NAUT Metrics
BasicAdvanced
$114m
-
-$0.45
0.81
-
Price and volume
Market cap
$114m
Beta
0.81
52-week high
$4.31
52-week low
$0.62
Average daily volume
971k
Financial strength
Current ratio
10.143
Quick ratio
9.727
Long term debt to equity
18.171
Total debt to equity
21.215
Profitability
EBITDA (TTM)
-61.346
Gross margin (TTM)
92.11%
Net profit margin (TTM)
-29,747.89%
Operating margin (TTM)
-33,043.68%
Management effectiveness
Return on assets (TTM)
-20.83%
Return on equity (TTM)
-36.21%
Valuation
Price to revenue (TTM)
599.8
Price to book
0.87
Price to tangible book (TTM)
0.87
Price to free cash flow (TTM)
-2.197
Free cash flow yield (TTM)
-45.53%
Free cash flow per share (TTM)
-0.41
Growth
Earnings per share change (TTM)
-14.44%
3-year earnings per share growth (CAGR)
-1.51%
What the Analysts think about NAUT
Analyst ratings (Buy, Hold, Sell) for Nautilus Biotechnolgy stock.
NAUT Financial Performance
Revenues and expenses
NAUT Earnings Performance
Company profitability
NAUT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.